|
 |
Bladder Cancer > Antibody
The following information is about Antibody.
Antibody Defined
Any of a large number of proteins that are produced normally by specialized B cells after stimulation by an antigen and act specifically against the antigen in an immune response
This definition is in context to Bladder Cancer. See more contextual defintions for Antibody.
Sarah Cannon Research Institute Presents New Findings in Breast Cancer Treatment
Published September 5, 2008, 9:20 am, Centre Daily Times
Sarah Cannon Research Institute (SCRI) investigators have found that "smart bomb" therapies are effective in treating breast cancer patients while minimizing side effects.
Change In HER2 Status After Treatment With Herceptin Discovered By M. D. Anderson Study
Published September 5, 2008, 7:15 am, Medical News Today
Researchers at The University of Texas M. D. Anderson Cancer Center have discovered that when treated with Herceptin prior to surgery, 50 percent of HER2 positive, breast cancer patients showed no signs of disease at the time of surgery.
Medarex Announces Presentations At The 33rd Congress Of The European Society For Medical Oncology
Published September 5, 2008, 6:14 am, Medical News Today
Medarex, Inc. (Nasdaq: MEDX) announced that nine clinical abstracts for ipilimumab, an investigational anti-CTLA-4 antibody, in melanoma are scheduled to be the subject of presentations at the 33rd Congress of the European Society for Medical Oncology (ESMO) being held September 12-16, 2008 in Stockholm.
Panacea wins new US patent for anti-HAAH antibodies
Published September 5, 2008, 2:45 am, Pharmaceutical Business Review
US-based biopharmaceutical company Panacea Pharmaceuticals has received a new US patent that covers antibodies against human aspartyl beta-hydroxylase, a proprietary human cancer biomarker and therapeutic target.
Genmab CEO eyes next big drug deal in 2009
Published September 4, 2008, 11:44 pm, Reuters via Yahoo! UK & Ireland News
Danish biotech company Genmab could sign a $1 billion-plus (569,000 pounds-plus) partnership deal for its experimental cancer drug zalutumumab next year if interim clinical trial results, expected in March, are positive.
Elan and Biogen Idec Initiate First Clinical Trial of TYSABRI(R) in Oncology
Published September 4, 2008, 11:23 pm, Centre Daily Times
Elan Corporation, plc (NYSE: ELN) and Biogen Idec (NASDAQ: BIIB) today announced the initiation of the first clinical trial of TYSABRI(R) (natalizumab) in oncology. The first dose of TYSABRI was administered yesterday in the trial. The objectives of this Phase I/II study are to evaluate the safety and potential anti-tumor activity of TYSABRI in patients with relapsed or refractory multiple ...
Elan and Biogen Idec Initiate First Clinical Trial of TYSABRI(R) in Oncology
Published September 4, 2008, 11:09 pm, wallstreet:online AG
Elan Corporation, plc (NYSE: ELN) and Biogen Idec (NASDAQ: BIIB) today announced the initiation of
Elan and Biogen Idec Initiate First Clinical Trial of TYSABRI(R) in Oncology
Published September 4, 2008, 11:00 pm, Business Wire via Yahoo! Finance
CAMBRIDGE, Mass. & DUBLIN, Ireland----Elan Corporation, plc and Biogen Idec today announced the initiation of the first clinical trial of TYSABRI® in oncology. The first dose of TYSABRI was administered yesterday in the trial.
Human Genome Sciences reports initial results from Phase II myeloma trial
Published September 4, 2008, 5:39 pm, Pharmaceutical Business Review
Human Genome Sciences has reported initial topline results from an ongoing randomized Phase II clinical trial of its Trail receptor antibody HGS-ETR1 in combination with bortezomib in patients with advanced multiple myeloma.
High Growth Forecasted for the World Automated and Rapid Microbiological Tests Market
Published September 4, 2008, 1:17 pm, Marketwire via Yahoo! Finance
Reportlinker.com announces that a new market research report related to the Biotechnologies and Genetics industry is available in its catalogue.
Are you looking for additional Bladder Cancer > Antibody news? Try our new "Antibody News Focus" area.
Off-site Antibody Links, User Submitted
The following links have been collected through user bookmark submission in the Antibody category. Please note, because these resources are off-site we cannot guarantee the accuracy or quality of any information.
Thu Aug 28
Tue Aug 26
Mon Aug 25
- Melbourne doctors move closer to wonder cures
- Antibody Engineering Cuts Collateral Damage of Cancer Drugs: Killing cancer cells, while leaving normal tissue unscathed, is almost impossible. Nanotechnology may do the trick, but big pharmaceutical companies are far from embracing that strategy. In the meantime, highly-enginee red biological molecules will fill the void.
Fri Aug 22
- CSF B--lymphocyte chemoattractan t (CXCL13) in the ...[J Neurol. 2008] - PubMed Result: Norway, 2008 (abstract only). A chemical in the spinal fluid, B-lymphocyte attracting chemokine (CXCL13) may be diagnostic for neurological Lyme disease, as shown in this study of 59 consecutive patients referred for possible neuroborrelios is.
Thu Aug 21
Mon Aug 18
- Remembrance of viruses past : Nature News
- www.bioinf.org .uk : Dr. Andrew C.R. Martin's Group at UCL: This page provides an automatically updated summary of all antibody structures in the Protein Databank
- TheStar.com | News & Features | Antibodies from 1918 flu still work well, study says
If you would like to find additional social bookmark based links on the topic of we recommend the Open Tag Directory > Antibody. If you would like to find related tags we recommend Tag Patterns > Antibody
Off-site Antibody Research Links
If you still need additional information on Antibody then we suggest the following off-site resources. Please note, because these resources are off-site we cannot guarantee the accuracy or quality of any information.
Bladder Cancer Topics
Everything you need to know about Bladder Cancer
Bladder Cancer
If you know the Bladder Cancer Term Name use the links below to quickly jump to your desired focus.
Bookmark Us
The On Topic Network
This website is part of The On Topic Network.
Thank You
Bladder-Cancer.On-Topic.net was developed by Odin Metatech, Inc and runs on the Odin Assemble platform.
Best Viewed With
License
This work is licensed under Creative Commons.